相似文献
1
HCC risk prediction using biomarkers in non-cirrhotic patients following HCV eradication: Reassuring the patient or the doctor?
JHEP Rep. 2021 Jun 12;3(4):100320. doi: 10.1016/j.jhepr.2021.100320. eCollection 2021 Aug.
2
Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
Virus Res. 2018 Aug 15;255:77-84. doi: 10.1016/j.virusres.2018.07.004. Epub 2018 Jul 9.
3
Circulating microRNAs (miR-21, miR-223, miR-885-5p) along the clinical spectrum of HCV-related chronic liver disease in Egyptian patients.
Arab J Gastroenterol. 2019 Dec;20(4):198-204. doi: 10.1016/j.ajg.2019.11.003. Epub 2019 Dec 2.
4
Proteomic analysis of HCV cirrhosis and HCV-induced HCC: identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation.
Transplantation. 2009 Jan 15;87(1):143-52. doi: 10.1097/TP.0b013e318191c68d.
5
Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus- and hepatitis C virus-infected individuals.
Aliment Pharmacol Ther. 2021 Sep;54(6):833-842. doi: 10.1111/apt.16524. Epub 2021 Jul 19.
6
Liver fibrosis indices for identifying patients at low risk of developing hepatocellular carcinoma after eradication of HCV.
Antivir Ther. 2017;22(3):185-193. doi: 10.3851/IMP3081. Epub 2016 Sep 2.
7
Serum microRNA let-7a-1/let-7d/let-7f and miRNA 143/145 Gene Expression Profiles as Potential Biomarkers in HCV Induced Hepatocellular Carcinoma.
Asian Pac J Cancer Prev. 2020 Feb 1;21(2):555-562. doi: 10.31557/APJCP.2020.21.2.555.
8
HCV Eradication in Primary or Secondary Prevention Optimizes Hepatocellular Carcinoma Curative Management.
Cancer Prev Res (Phila). 2021 May;14(5):581-592. doi: 10.1158/1940-6207.CAPR-20-0465. Epub 2021 Feb 19.
9
Hepatitis C virus-associated primary hepatocellular carcinoma in non-cirrhotic patients.
Dig Dis Sci. 2012 Dec;57(12):3265-70. doi: 10.1007/s10620-012-2260-y. Epub 2012 Jun 14.
10
Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication.
J Hepatol. 2014 Jul;61(1):67-74. doi: 10.1016/j.jhep.2014.02.022. Epub 2014 Mar 5.
引用本文的文献
1
Outcome after Resection for Hepatocellular Carcinoma in Noncirrhotic Liver-A Single Centre Study.
J Clin Med. 2022 Sep 30;11(19):5802. doi: 10.3390/jcm11195802.
本文引用的文献
1
External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV.
JHEP Rep. 2021 Apr 24;3(4):100298. doi: 10.1016/j.jhepr.2021.100298. eCollection 2021 Aug.
2
We need stronger evidence for (or against) hepatocellular carcinoma surveillance.
J Hepatol. 2021 May;74(5):1234-1239. doi: 10.1016/j.jhep.2020.12.029. Epub 2021 Jan 17.
3
Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status.
J Hepatol. 2020 Dec;73(6):1434-1445. doi: 10.1016/j.jhep.2020.05.052. Epub 2020 Jun 29.
4
Management of patients with pre-therapeutic advanced liver fibrosis following HCV eradication.
JHEP Rep. 2019 Nov 18;1(6):480-489. doi: 10.1016/j.jhepr.2019.11.001. eCollection 2019 Dec.
5
Hepatocellular carcinoma surveillance with liver imaging is not associated with improved survival.
Scand J Gastroenterol. 2020 Feb;55(2):222-227. doi: 10.1080/00365521.2020.1718747. Epub 2020 Jan 28.
6
LCR1 and LCR2, two multi-analyte blood tests to assess liver cancer risk in patients without or with cirrhosis.
Aliment Pharmacol Ther. 2019 Feb;49(3):308-320. doi: 10.1111/apt.15082. Epub 2018 Dec 19.
7
Magnetic Resonance Imaging Is Cost-Effective for Hepatocellular Carcinoma Surveillance in High-Risk Patients With Cirrhosis.
Hepatology. 2019 Apr;69(4):1599-1613. doi: 10.1002/hep.30330. Epub 2019 Feb 25.
8
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.
J Hepatol. 2018 Jul;69(1):182-236. doi: 10.1016/j.jhep.2018.03.019. Epub 2018 Apr 5.
9
Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.
Gastroenterology. 2018 May;154(6):1706-1718.e1. doi: 10.1053/j.gastro.2018.01.064. Epub 2018 Feb 6.
10
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.
Hepatol Int. 2017 Jul;11(4):317-370. doi: 10.1007/s12072-017-9799-9. Epub 2017 Jun 15.
Zotero 插件